Abstract
This study demonstrates that immunodepressed trauma patients' monocytes produce elevated interleukin-6 to adherence, bacterial, and cytokine stimulation compared to immunocompetent trauma patients' or normals' monocytes, suggesting theirin vivo preactivation possibly mediated by the hyperimmunoglobulinemia which characterizes these patients. Furthermore, stimulation of monocytes through cross-linking their FcγRI induces and augments interleukin-6 (IL-6) production to subsequent stimulation both in trauma patients' (P<0.001) and in normals' (P<0.001) monocytes. As we reported earlier, immunodepressed trauma patients have an increased proportion of FcγRI-bearing monocytes in their total monocyte population and here we show that those FcγRI+ monocytes produce significantly elevated interleukin-6, suggesting a relationship between elevated monocyte interleukin-6 production and FcγRI triggering. Interleukin-6 induction by FcRI stimulation is not mediated solely by FcRI-induced MØ tumor necrosis factor alpha, IL-1α, or IL-1β production and is independent of MØ prostaglandin E2 levels. Therefore, FcRI stimulation-induced elevated MØ IL-6 might contribute to the increased immunoglobulin levels posttrauma.
Similar content being viewed by others
References
Faist E, Mewes A, Baker CC, Strasser T, Alkan SS, Rieber P, Heberer G: Prostaglandin E2 (PGE2)-dependent suppression of interleukin α (IL-2) production in patients with major trauma. J Trauma 27:837–848, 1987
Miller-Graziano CL, Fink M, Wu JY, Szabo G, Kodys K: Mechanisms of monocyte prostaglandin E2 production in severely injured patients. Arch Surg 123:293–299, 1988
Baker CC, Yamada AH, Faist E, Kupper TS: Interleukin-1 and T cell function following injury. JBCR 8:503–508, 1987
Faist E, Mewes A, Strasser T, Walz A, Alkan S, Baker C, Ertel W, Heberer G: Alteration of monocyte function following major injury. Arch Surg 123:287–292, 1988
Takayama TK, Miller C, Szabo G: Elevated tumor necrosis factorα production concomitant to elevated prostaglandin E2 production by trauma patients' monocytes. Arch Surg 125:29–35, 1990
Beutler B: Cachectin in tissue injury, shock and related states. Crit Care Clinics 5:353–367, 1989
Green DR, Faist E: Trauma and the immune response. Immunol Today 9:253–255, 1988
Dobke M, Sztaba-Kania M: The occurrence of immune complexes in patients with thermal injuries.In Traumatic Injury, JL Ninnemann (ed). Baltimore, University Park Press, 1983, pp 153–161
Ertel W, Faist E, Nestle C, Schuebel I, Storck M, Schildberg FW: Dynamics of immunoglobulin synthesis after major trauma. Arch Surg 124:1437–1442, 1989
Nijsten MWN, de Groot ER, ten Duis HJ, Klasen HJ, Hack CE, Aarden LA: Serum levels of interleukin-6 and acute phase responses. Lancet 2:921 1987 (abstr)
Hack CE, De Groot ER, Felt-Bersma RJF, Nuijens JH, Van Schijndel RJMS, Eerenberg-Belmer AJM, Thijs LG, Aarden LA: Increased plasma levels of interleukin-6 in sepsis. Blood 74:1704–1710, 1989
Nishimoto N, Yoshizaki K, Tagoh H, Monden M, Kishimoto S, Hirano S, Kishimoto T: Elevation of serum interleukin 6 prior to acute phase proteins on the inflammation by surgical operation. Clin Immunol Immunopathol 50:399–401, 1989
Guo Y, Dickerson C, Chrest FJ, Adler WH, Munster AM, Winchurch RA: Increased levels of circulating interleukin 6 in burn patients. Clin Immunol Immunopathol 54:361–371, 1990
Ray A, Tatter SB, Santhanam U, Helfgott DC, May LT, Sehgal PB: Regulation of expression of interleukin-6.In Regulation of the Acute Phase and Immune Responses: Interleukin-6, Vol 557, PB Sehgal, G Grieninger, G Tosato (eds). New York, New York Academy of Sciences, 1989, pp 353–362
Aarden LA, De Groot ER, Schaap OL, Lansdorp PM: Production of hybridoma growth factor by human monocytes. Eur J Immunol 17:1411–1416, 1987
Kato K, Yokoi T, Takano N, Kanegane H, Yachie A, Miyawaki T, Taniguchi N: Detection by in situ hybridization and phenotypic characterization of cells expressing IL-6 mRNA in human stimulated blood. J Immunol 144:1317–1322, 1990
Helfgott DC, May LT, Sthoeger Z, Tamm I, Sehgal PB: Bacterial lipopolysaccharide (endotoxin) enhances expression and secretion of β2 interferon by human fibroblasts. J Exp Med 166:1300–1309, 1987
Shalaby MR, Waage A, Espevik T: Cytokine regulation of interleukin 6 production by human endothelial cells. Cell Immunol 121:372–382, 1989
Muraguchi A, Hirano T, Tang B, Matsuda T, Horii Y, Nakajima K, Kishimoto T: The essential role of B cell stimulatory factor 2 (BSF-2/IL-6) for the terminal differentiation of B cells. J Exp Med 167:332–344, 1988
Kishimoto T: B-cell stimulatory factors (BSFs): Molecular structure, biological function, and regulation of expression. J Clin Immunol 7:343–355, 1987
Navarro S, Debili N, Bernaudin J-F, Vainchenker W, Doly J: Regulation of the expression of IL-6 in human monocytes. J Immunol 142:4339–4345, 1989
Sanceau J, Beranger F, Gaudelet C, Wietzerbin J: IFN-γ is an essential cosignal for triggering IFN-β2/BSF-2/IL-6 gene expression in human monocytic cell lines.In Regulation of the Acute Phase and Immune Responses: Interleukin-6, Vol 557, PB Sehgal, G Grieninger, G Tosato (eds). New York, New York Academy of Sciences, 1989, pp 130–143
Kurlander RJ, Batker J: The binding of human immunoglobulin G1 monomer and small, covalently cross-linked polymers of immunoglobulin G1 to human peripheral blood monocytes and polymorphonuclear leukocytes. J Clin Invest 69:1–8, 1982
Debets JMH, van der Linden CJ, Dieteren IEM, Leeuwenberg JFM, Buurman WA: Fc-receptor cross-linking induces rapid secretion of tumor necrosis factor (cachectin) by human peripheral blood monocytes. J Immunol 141:1197–1201, 1988
Rouzer CA, Scott WA, Kempe J, Cohn ZA: Prostaglandin synthesis by macrophages requires a specific receptor-ligand interaction. Proc Natl Acad Sci 77:4279–4282, 1980
Szabo G, Miller-Graziano CL, Wu J-Y, Takayama T, Kodys K: Differential tumor necrosis factor production by human monocyte subsets. J Leuk Biol 47:206–216, 1990
Jayaram Y, Buckle AM, Hogg N: The Fc receptor, FcRI, and other activation molecules on human mononuclear phagocytes after treatment with interferon-gamma. Clin Exp Immunol 75:414–420
Morland B, Morland H: The interaction of ethanol with human monocyte IgG-Fc receptors, characterized by monoclonal antibodies raised against two distinct receptor subpopulations. Scand J Immunol 29:573–577, 1989
Pryjma J, Pituch-Noworolska A, Ruggiero I, Zembala M: The regulation of polyclonal immunoglobulin synthesis by FcR+ and FcR− monocyte subsets. Clin Immunol Immunopathol 37:245–252, 1985
Miller-Graziano C, Szabo G, Takayama T, Wu J-Y: Alterations of monocyte function following major surgery.In The Immune Consequences of Trauma, Shock, and Sepsis, E Faist (ed). Berlin, Springer-Verlag, 1989, pp 95–109
Krutmann J, Kirnbauer R, Köck A, Schwarz T, Schöpf E, May LT, Sehgal PB, Luger TA: Cross-linking Fc receptors on monocytes triggers IL-6 production. J Immunol 145:1337–1342, 1990
Looney RJ, Abraham GN, Anderson CL: Human monocytes and U937 cells bear two distinct Fc receptors for IgG. J Immunol 136:1641–1647, 1986
Pradelles P, Grassi J, Macloui J: Enzyme immunoassays of eicosanoids using acetylcholine esterase as label: An alternative to radioimmunoassay. Anal Chem 57:1170–1173, 1985
Jacob CO, Fronek Z, Lewis GD, Koo M, Hansen JA, McDevitt HO: Heritable major histocompatibility complex class II-associated differences in production of tumor necrosis factor α: relevance to genetic predisposition to systemic lupus erythematosus. Proc Natl Acad Sci 87:1233–1237, 1990
Pullicino EA, Carli F, Poole S, Rafferty B, Malik STA, Elia M: The relationship between the circulating concentrations of interleukin 6 (IL-6), tumor necrosis factor (TNF) and the acute phase response to elective surgery and accidental injury. Lymph Res 9:231–238, 1990
Ayala A, Wang P, Ba ZF, Perrin MM, Ertel W, Chaudry IH: Differential alterations in plasma IL-6 and TNF levels after trauma and hemorrhage. Am J Physiol 210:R167-R171, 1991
Faist E, Ertel W, Mewes A, Strasser T, Walz A, Alkan S: Mediators and the trauma induced cascade of immunologic defects. Prog Clin Biol Res 308:495–506, 1989
Oppenheim JJ, Kovacs EJ, Matsushima K, Durum SK: There is more than one interleukin 1. Immunol Today 7(2):45–56, 1986
Fong Y, Moldawer LL, Marano M, Wei H, Tatter SB, Clarick RH, Santhanam U, Sherris D, May LT, Sehgal PB, Lowry SF: Endotoxemia elicits increased circulating β2-IFN/IL-6 in man. J Immunol 142:2321–2324, 1989
Fong Y, Tracey KJ, Moldawer LL, Hesse DG, Manogue KB, Kenney JS, Lee AT, Kuo GC, Allison AC, Lowry SF, Cerami A: Antibodies to cachectin/tumor necrosis factor reduce interleukin-1β and interleukin 6 appearance during lethal bacteremia. J Exp Med 170:1627–1633, 1989
Anderson CL, Guyre PM, Whitin JC, Ryan DH, Looney RJ, Fanger MW: Monoclonal antibodies to Fc receptors for IgG on human mononuclear phagocytes. J Biol Chem 261:12856–12864, 1986
Szabo G, Miller C: Induction and regulation of monocyte procoagulant activity. Transplantation 50:301–309, 1990
Eisenberg SP, Evans RJ, Arend WP, Verderber E, Brewer MT, Hannum CH, Thompson RC: Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist. Nature 343:341–346, 1990
Ling Z-D, Ziltener HJ, Webb BT, Matheson DS: Aggregated immunoglobulin and Fc fragment of IgG induce IL-6 release from human monocytes. Cell Immunol 129:95–103, 1990
Debets JMH, Can De Winkel JGJ, Ceuppens JL, Dieteren IEM, Buurman WA: Cross-linking of both FcγRI and FcγRII induces secretion of tumor necrosis factor by human monocytes, requiring high affinity Fc-FcγR interactions. J Immunol 144:1304–1310, 1990
Chensue SW, Terebuh PD, Remick DG, Scales WE, Kunkel SL: In vivo biologic and immunohistochemical analysis of interleukin-1 alpha, beta and tumor necrosis factor during experimental endotoxemia. Am J Pathol 138(2):395–402, 1991
Ertel W, Morrison MH, Ayala A, Perrin MM, Chaudry IH: Interferon-γ (IFNγ) administrationin vivo following hemorrhagic shock restores macrophage (MØ) antigen presentation and the processes with it. Circ Shock 31:30, 1990
Balavoine J-F, de Rochemonteix B, Williamson K, Seckinger P, Cruchaud A, Dayer D-M: Prostaglandin E2 and collagenase production by fibroblasts and synovial cells is regulated by urine-derived human interleukin 1 and inhibitor(s). J Clin Invest 78:1120–1124, 1986
Spengler RN, Spengler ML, Strieter RM, Remick DG, Larrick JW, Kunkel SL: Modulation of tumor necrosis factor-α gene expression. J Immunol 142:4346–4350, 1989
Renz H, Gong J-H, Schmidt A, Nain M, Gemsa D: Release of tumor necrosis factor-α from macrophages. J Immunol 141:2388–2393, 1988
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Szabo, G., Kodys, K. & Miller-Graziano, C.L. Elevated monocyte interleukin-6 (IL-6) production in immunosuppressed trauma patients. I. Role of FcγRI cross-linking stimulation. J Clin Immunol 11, 326–335 (1991). https://doi.org/10.1007/BF00918798
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00918798